Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer.

Yang L, Wang B, Qin J, Zhou H, Majumdar APN, Peng F.

Immunopharmacol Immunotoxicol. 2018 Feb;40(1):91-97. doi: 10.1080/08923973.2017.1417997. Epub 2018 Jan 5.

PMID:
29303012
2.

A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells.

Yu Y, Nangia-Makker P, Farhana L, Majumdar APN.

Mol Cancer. 2017 Sep 30;16(1):155. doi: 10.1186/s12943-017-0725-5.

3.

Bile acid: a potential inducer of colon cancer stem cells.

Farhana L, Nangia-Makker P, Arbit E, Shango K, Sarkar S, Mahmud H, Hadden T, Yu Y, Majumdar AP.

Stem Cell Res Ther. 2016 Dec 1;7(1):181.

4.

Racial disparity in colorectal cancer: Gut microbiome and cancer stem cells.

Goyal S, Nangia-Makker P, Farhana L, Yu Y, Majumdar AP.

World J Stem Cells. 2016 Sep 26;8(9):279-87. doi: 10.4252/wjsc.v8.i9.279. Review.

5.

Associations between markers of colorectal cancer stem cells, mutation, microRNA and the clinical features of ulcerative colitis.

Yang L, Levi E, Du JH, Zhou HH, Miller R, Majumdar AP.

Colorectal Dis. 2016 Jun;18(6):O185-93. doi: 10.1111/codi.13371.

PMID:
27153478
6.

Role of cancer stem cells in racial disparity in colorectal cancer.

Farhana L, Antaki F, Anees MR, Nangia-Makker P, Judd S, Hadden T, Levi E, Murshed F, Yu Y, Van Buren E, Ahmed K, Dyson G, Majumdar AP.

Cancer Med. 2016 Jun;5(6):1268-78. doi: 10.1002/cam4.690. Epub 2016 Mar 14.

7.

Role of cancer stem cells in age-related rise in colorectal cancer.

Nangia-Makker P, Yu Y, Majumdar AP.

World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):86-9. doi: 10.4291/wjgp.v6.i4.86.

8.

miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.

Yu Y, Nangia-Makker P, Farhana L, G Rajendra S, Levi E, Majumdar AP.

Mol Cancer. 2015 May 1;14:98. doi: 10.1186/s12943-015-0372-7.

9.

Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.

Sharon C, Baranwal S, Patel NJ, Rodriguez-Agudo D, Pandak WM, Majumdar AP, Krystal G, Patel BB.

Oncotarget. 2015 Jun 20;6(17):15332-47.

10.

Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer.

Vasudevan A, Yu Y, Banerjee S, Woods J, Farhana L, Rajendra SG, Patel A, Dyson G, Levi E, Maddipati KR, Majumdar AP, Nangia-Makker P.

Cancer Prev Res (Phila). 2014 Nov;7(11):1138-48. doi: 10.1158/1940-6207.CAPR-14-0177. Epub 2014 Sep 5.

11.

Cancer stem cells in Helicobacter pylori infection and aging: Implications for gastric carcinogenesis.

Levi E, Sochacki P, Khoury N, Patel BB, Majumdar AP.

World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):366-72. doi: 10.4291/wjgp.v5.i3.366.

12.

Metformin: a potential therapeutic agent for recurrent colon cancer.

Nangia-Makker P, Yu Y, Vasudevan A, Farhana L, Rajendra SG, Levi E, Majumdar AP.

PLoS One. 2014 Jan 20;9(1):e84369. doi: 10.1371/journal.pone.0084369. eCollection 2014.

13.

Cancer stem cells biomarkers in gastric carcinogenesis.

Yang L, Levi E, Zhu S, Du J, Majumdar AP.

J Gastrointest Cancer. 2013 Dec;44(4):428-35. doi: 10.1007/s12029-013-9534-2.

PMID:
23949555
14.

Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21.

Roy S, Yu Y, Padhye SB, Sarkar FH, Majumdar AP.

PLoS One. 2013 Jul 24;8(7):e68543. doi: 10.1371/journal.pone.0068543. Print 2013.

15.

Cancer Stem Cells in Colorectal Cancer: Genetic and Epigenetic Changes.

Roy S, Majumdar AP.

J Stem Cell Res Ther. 2012 Dec 17;Suppl 7(6). pii: 10342.

16.
17.

Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.

Roy S, Levi E, Majumdar AP, Sarkar FH.

J Hematol Oncol. 2012 Sep 19;5:58. doi: 10.1186/1756-8722-5-58.

18.

Signaling in colon cancer stem cells.

Roy S, Majumdar AP.

J Mol Signal. 2012 Aug 6;7(1):11. doi: 10.1186/1750-2187-7-11.

19.

Auraptene and its effects on the re-emergence of colon cancer stem cells.

Epifano F, Genovese S, Miller R, Majumdar AP.

Phytother Res. 2013 May;27(5):784-6. doi: 10.1002/ptr.4773. Epub 2012 Jul 4.

20.

Associations between markers of colorectal cancer stem cells and adenomas among ethnic groups.

Leavell BJ, Van Buren E, Antaki F, Axelrod BN, Rambus MA, Majumdar AP.

Dig Dis Sci. 2012 Sep;57(9):2334-9. doi: 10.1007/s10620-012-2195-3. Epub 2012 May 6.

21.

Regulation of colon cancer recurrence and development of therapeutic strategies.

Kanwar SS, Poolla A, Majumdar AP.

World J Gastrointest Pathophysiol. 2012 Feb 15;3(1):1-9. doi: 10.4291/wjgp.v3.i1.1.

22.

EGFR regulation of colon cancer stem-like cells during aging and in response to the colonic carcinogen dimethylhydrazine.

Nautiyal J, Du J, Yu Y, Kanwar SS, Levi E, Majumdar AP.

Am J Physiol Gastrointest Liver Physiol. 2012 Apr;302(7):G655-63. doi: 10.1152/ajpgi.00323.2011. Epub 2012 Jan 26.

23.

Cancer stem cells in ulcerative colitis.

Levi E, Majumdar AP.

Onkologie. 2011;34(12):660-2. doi: 10.1159/000334812. Epub 2011 Nov 21. No abstract available.

PMID:
22156444
24.

MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells.

Yu Y, Kanwar SS, Patel BB, Oh PS, Nautiyal J, Sarkar FH, Majumdar AP.

Carcinogenesis. 2012 Jan;33(1):68-76. doi: 10.1093/carcin/bgr246. Epub 2011 Nov 9.

25.

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells.

Nautiyal J, Kanwar SS, Yu Y, Majumdar AP.

J Mol Signal. 2011 Jul 20;6:7. doi: 10.1186/1750-2187-6-7.

26.

Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.

Oh PS, Patel VB, Sanders MA, Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar AP.

Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G347-55. doi: 10.1152/ajpgi.00403.2010. Epub 2011 May 19.

27.

Colon cancer stem cells: implications in carcinogenesis.

Sanders MA, Majumdar AP.

Front Biosci (Landmark Ed). 2011 Jan 1;16:1651-62. Review.

28.

Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells.

Kanwar SS, Yu Y, Nautiyal J, Patel BB, Padhye S, Sarkar FH, Majumdar AP.

Pharm Res. 2011 Apr;28(4):827-38. doi: 10.1007/s11095-010-0336-y. Epub 2010 Dec 14.

29.

Colorectal cancer: chemopreventive role of curcumin and resveratrol.

Patel VB, Misra S, Patel BB, Majumdar AP.

Nutr Cancer. 2010;62(7):958-67. doi: 10.1080/01635581.2010.510259. Review.

30.

Do nutraceutics play a role in the prevention and treatment of colorectal cancer?

Markle B, May EJ, Majumdar AP.

Cancer Metastasis Rev. 2010 Sep;29(3):395-404. doi: 10.1007/s10555-010-9234-3. Review.

PMID:
20717706
31.

The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres.

Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar AP.

Mol Cancer. 2010 Aug 6;9:212. doi: 10.1186/1476-4598-9-212.

32.

ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells.

Nautiyal J, Yu Y, Aboukameel A, Kanwar SS, Das JK, Du J, Patel BB, Sarkar FH, Rishi AK, Mohammad RM, Majumdar AP.

Mol Cancer Ther. 2010 Jun;9(6):1503-14. doi: 10.1158/1535-7163.MCT-10-0019. Epub 2010 Jun 1. Erratum in: Mol Cancer Ther. 2010 Sep;9(9):2637.

33.

EGFR(s) in aging and carcinogenesis of the gastrointestinal tract.

Nautiyal J, Kanwar SS, Majumdar AP.

Curr Protein Pept Sci. 2010 Sep;11(6):436-50. Review.

34.

Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.

Nautiyal J, Banerjee S, Kanwar SS, Yu Y, Patel BB, Sarkar FH, Majumdar AP.

Int J Cancer. 2011 Feb 15;128(4):951-61. doi: 10.1002/ijc.25410.

35.

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

Patel BB, Gupta D, Elliott AA, Sengupta V, Yu Y, Majumdar AP.

Anticancer Res. 2010 Feb;30(2):319-25.

36.

Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer.

Kato I, Land S, Majumdar AP, Barnholtz-Sloan J, Severson RK.

Cancer Epidemiol. 2010 Jun;34(3):291-7. doi: 10.1016/j.canep.2010.02.010. Epub 2010 Mar 21.

37.

Schlafen 3 induction by cyclic strain regulates intestinal epithelial differentiation.

Yuan L, Yu Y, Sanders MA, Majumdar AP, Basson MD.

Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G994-G1003. doi: 10.1152/ajpgi.00517.2009. Epub 2010 Mar 18.

38.

EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?

Kanwar SS, Nautiyal J, Majumdar AP.

Curr Drug Targets. 2010 Jun;11(6):682-98. Review.

39.

DNA/RNA markers for colorectal cancer risk in preserved stool specimens: a pilot study.

Kato I, Badsha KZ, Land S, Nechvatal JM, Matherly LH, Tarca AL, Majumdar AP, Basson MD, Ram JL.

Tumori. 2009 Nov-Dec;95(6):753-61.

40.

Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview.

Patel BB, Majumdar AP.

Nutr Cancer. 2009;61(6):842-6. doi: 10.1080/01635580903285106. Review.

PMID:
20155625
41.

Smoking and other personal characteristics as potential predictors for fecal bacteria populations in humans.

Kato I, Nechvatal JM, Dzinic S, Basson MD, Majumdar AP, Ram JL.

Med Sci Monit. 2010 Jan;16(1):CR1-7.

42.

Dietary fatty acids, luminal modifiers, and risk of colorectal cancer.

Kato I, Majumdar AP, Land SJ, Barnholtz-Sloan JS, Severson RK.

Int J Cancer. 2010 Aug 15;127(4):942-51. doi: 10.1002/ijc.25103.

43.

Aging and inflammation: etiological culprits of cancer.

Ahmad A, Banerjee S, Wang Z, Kong D, Majumdar AP, Sarkar FH.

Curr Aging Sci. 2009 Dec;2(3):174-86. Review.

44.

Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX.

Yu Y, Kanwar SS, Patel BB, Nautiyal J, Sarkar FH, Majumdar AP.

Transl Oncol. 2009 Dec;2(4):321-8.

45.

Curcumin synergizes with resveratrol to inhibit colon cancer.

Majumdar AP, Banerjee S, Nautiyal J, Patel BB, Patel V, Du J, Yu Y, Elliott AA, Levi E, Sarkar FH.

Nutr Cancer. 2009;61(4):544-53. doi: 10.1080/01635580902752262.

PMID:
19838927
46.

Schlafen-3: a novel regulator of intestinal differentiation.

Patel VB, Yu Y, Das JK, Patel BB, Majumdar AP.

Biochem Biophys Res Commun. 2009 Oct 30;388(4):752-6. doi: 10.1016/j.bbrc.2009.08.094. Epub 2009 Aug 22.

47.

Combination of aging and dimethylhydrazine treatment causes an increase in cancer-stem cell population of rat colonic crypts.

Levi E, Misra S, Du J, Patel BB, Majumdar AP.

Biochem Biophys Res Commun. 2009 Jul 31;385(3):430-3. doi: 10.1016/j.bbrc.2009.05.080. Epub 2009 May 22.

48.

Src inhibitor dasatinib inhibits growth of breast cancer cells by modulating EGFR signaling.

Nautiyal J, Majumder P, Patel BB, Lee FY, Majumdar AP.

Cancer Lett. 2009 Oct 8;283(2):143-51. doi: 10.1016/j.canlet.2009.03.035. Epub 2009 Apr 26.

PMID:
19398150
49.

Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells.

Giri B, Gomes A, Sengupta R, Banerjee S, Nautiyal J, Sarkar FH, Majumdar AP.

Anticancer Res. 2009 Jan;29(1):395-401.

50.

Schlafen 3, a novel gene, regulates colonic mucosal growth during aging.

Patel BB, Yu Y, Du J, Rishi AK, Sarkar FH, Tarca AL, Wali A, Majumdar AP.

Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G955-62. doi: 10.1152/ajpgi.90726.2008. Epub 2009 Feb 19.

Supplemental Content

Loading ...
Support Center